2021 Volume 31 Issue 1 Pages 2-7
ONO Pharmaceutical has taken a new step toward further challenges beyond the major milestone of the 300th anniversary, since its establishment in 1717 as an apothecary by Ichibei Fushimiya in Doshomachi, Osaka. To be a “Global Specialty Pharma”, who can continuously develop and launch new innovative drugs that deliver true benefit to patients in global market, Ono has been evolving our drug discovery style, e.g. focusing on the prioritized disease areas, adopting several new modalities, establishment of ONO Pharma foundation and Ono Venture Investment in order to accelerate innovative collaboration. Here we describe drug discovery activities at ONO to date and recent changes surrounding medicinal chemists.
